Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1194-1196

  Mahlknecht, Philipp ^a   Stockner, Heike ^a   Kiechl, Stefan ^a   Willeit, Johann ^a   Rastner, Verena ^a   Gasperi, Arno ^b   Rungger, Gregor ^b   Poewe, Werner ^a   Seppi, Klaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Hospital of Bruneck   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; REPRODUCIBILITY OF RESULTS; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84864766037     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25071     Document Type: Letter

References (7)

1. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008; 7: 1044-1055.
2. Stockner H, Iranzo A, Seppi K, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2009; 24: 1906-1909.
3. Berg D, Seppi K, Behnke S, et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011; 68: 932-937.
4. Schrag A, Ben-Shlomo Y, Quinn NP. Cross-sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 2000; 321: 21-22.
5. Diaz-Corrales FJ, Sanz-Viedma S, Garcia-Solis D, Escobar-Delgado T, Mir P. Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease. Eur J Nucl Med Mol Imaging 2010; 37: 556-564.
6. Jabs BE, Bartsch AJ, Pfuhlmann B. Susceptibility to neuroleptic-induced parkinsonism-age and increased substantia nigra echogenicity as putative risk factors. Eur Psychiatry 2003; 18: 177-181.
7. Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001; 50: 463-467.